Verastem reported $246.44M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
AbbVie USD 136.46B 2.5B Mar/2026
Alaunos Therapeutics USD 1.88M 1.08M Mar/2026
AstraZeneca USD 114.02B 59M Mar/2026
Curis USD 19.97M 9.27M Dec/2025
Cytokinetics USD 1.27B 151.06M Mar/2026
Gilead Sciences USD 56.28B 2.74B Mar/2026
Incyte USD 7.34B 381.14M Mar/2026
Laboratory Of America USD 19.09B 694.4M Mar/2026
Novartis USD 118.53B 7.58B Mar/2026
Pfizer USD 207.62B 542M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
TG Therapeutics USD 1.53B 465.58M Mar/2026
Verastem USD 246.44M 69.59M Dec/2025